Page 1 of Clinical Trials for NGMN, 13 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women
Last Updated: February 15, 2012
Condition(s): Healthy Volunteers
2
Completed
Bioequivalence Study of Patches With Different Release Profiles
Last Updated: June 6, 2011
Condition(s): Female Contraception
3
Completed
Bioequivalence Study of Patches With Different Equilibration Profiles
Last Updated: June 6, 2011
Condition(s): Female Contraception
4
Completed
A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)
Last Updated: June 9, 2011
Condition(s): Contraception; Female Contraception
5
Completed
Drug Interaction Oral Contraceptive Pill (OCP)
Last Updated: January 24, 2011
Condition(s): Hepatitis C Virus
6
Active, not recruiting
Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks
Last Updated: May 18, 2011
Condition(s): Contraception; Female Contraception
7
Completed
A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)
Last Updated: June 6, 2011
Condition(s): Contraception; Female Contraception
8
Completed
A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers
Last Updated: June 6, 2011
Condition(s): Contraception; Female Contraception
9
Completed
A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM) /Ethinyl Estradiol (EE) in Healthy Women.
Last Updated: June 6, 2011
Condition(s): Drug Interactions; Healthy; Pharmacokinetics
10
Completed
Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.
Last Updated: June 6, 2011
Condition(s): Pharmacokinetics; Therapeutic Equivalency; Contraceptives, Oral
11
Completed
Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.
Last Updated: June 6, 2011
Condition(s): Female Contraception; Contraception; Therapeutic Equivalency; Pharmacokinetics
12
Completed
A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) in Healthy Women.
Last Updated: June 6, 2011
Condition(s): Drug Interactions; Contraception; Pharmacokinetics
13
Completed
Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women
Last Updated: May 17, 2012
Condition(s): HIV Infections; Pregnancy

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=NGMN

Page 1 of Clinical Trials for NGMN, 13 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About